Effectiveness and safety of Korean red ginseng extracts (KGC05P0) on improving blood glucose in adults with prediabetes: A randomized, double-blind, placebo-controlled trial

Korea Ginseng Corporation0 个研究点目标入组 120 人开始时间: 待定最近更新: 2020年2月24日

试验速览

暂无简介。

•1) Male or female adults aged 19 to 64
•2) Participant who satisfies one of the followings;
•a. fasting blood glucose level between 100 and 125 mg/dL
•b. blood glucose level between 140 and 199 mg/dL with oral glucose tolerance test
•c. HbA1C level between 5.7 and 6.4%
•3) Participants who voluntarily assent to participate in the study and sign the informed consents

•1) Participants taking hypoglycemic agents within 3 months
•2) Patients diagnosed with thyroid diseases and under their treatments
•3) Patients diagnosed with chronic gastrointestinal disorders
•4) Uncontrolled hypertensive patients
•5) Patients taking continuous treatments due to significantly glycometabolism-related disorders
•6) Participants with 30kg/m2 or more of body mass index
•7) Participants with renal dysfunction (1.5 times or more of upper limit of normal creatinine level), hepatic dysfunction (2.5 times or more of upper limits of normal alanine and aspartate aminotransferase levels), malignant tumors, or mental diseases
•8) Participants who took any medications, herb medicines, or functional supplements for 3 days or more within 4 weeks
•9) Pregnant or lactating females
•10) Participants who took any surgeries due to significantly glycometabolism-related disorders within recent 6 months
•11) Participants who have ever addicted to any drugs or alcohol
•12) Participants who participated in other clinical studies within 1 month
•13) Participants who are allergic or overreactive to the investigator’s product
•14) Participants who are illiterate or cannot read written letters
•15) Participants who have any other inappropriate reasons to participant in the study, judged by the investigators

发起方